Dividend Declaration

RNS Number : 5844G

Hikma Pharmaceuticals Plc

13 May 2011

 



Hikma Pharmaceuticals PLC

Final Dividend for 2010

LONDON, 13 May 2011 - Hikma Pharmaceuticals PLC ("the Company") advises that at its Annual General Meeting of shareholders, held on 12 May 2011, the final dividend of 7.5 cents per share was approved by shareholders. The dividend will be paid on 26 May 2011 to shareholders on the register on 15 April 2011. 

Shareholders who have elected to receive their dividend in Pounds Sterling will receive approximately 4.6 pence per Ordinary Share (exchange rate US$1.6278 to GBP£1).

- ENDS -

Enquiries:

Hikma Pharmaceuticals PLC
Henry Knowles Company Secretary	[phone]
Susan Ringdal Investor Relations Director	[phone]

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products.  Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics".  Hikma's operations are based principally in the Middle East and North Africa ("MENA") region, where it is a market leader and sells across 17 countries, the United States and Europe.  In 2010, the Group achieved revenues of $731 million (2009 $637 million) and profit attributable to shareholders was $99 million (2009 $78 million). 

 

END

 

 

DIVAJMJTMBMBBJB